152 related articles for article (PubMed ID: 21756011)
21. Burden of venous leg ulcers in the United States.
Rice JB; Desai U; Cummings AK; Birnbaum HG; Skornicki M; Parsons N
J Med Econ; 2014 May; 17(5):347-56. PubMed ID: 24625244
[TBL] [Abstract][Full Text] [Related]
22. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Parasuraman S; Thiel E; Park J; Teschemaker A
J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
[TBL] [Abstract][Full Text] [Related]
23. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
24. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
Lage MJ; Gross GN; Brewster C; Spalitto A
Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
[TBL] [Abstract][Full Text] [Related]
25. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
26. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
27. Health, social, and economic consequences of neck injuries: a controlled national study evaluating societal effects on patients and their partners.
Jennum P; Kjellberg J; Ibsen R; Bendix T
Spine (Phila Pa 1976); 2013 Mar; 38(5):449-57. PubMed ID: 23238487
[TBL] [Abstract][Full Text] [Related]
28. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
29. Impact of neutropenic complications on short-term disability in patients with cancer receiving chemotherapy.
Song X; Fowler R; Ruiz K; Hurley D; Barron RL
J Med Econ; 2009 Jun; 12(2):154-63. PubMed ID: 19594323
[TBL] [Abstract][Full Text] [Related]
30. The direct and indirect costs among U.S. privately insured employees with hypogonadism.
Kaltenboeck A; Foster S; Ivanova J; Diener M; Bergman R; Birnbaum H; Kinchen K; Swindle R
J Sex Med; 2012 Sep; 9(9):2438-47. PubMed ID: 22738380
[TBL] [Abstract][Full Text] [Related]
31. Cost and utilization of COPD and asthma among insured adults in the US.
Blanchette CM; Broder M; Ory C; Chang E; Akazawa M; Dalal AA
Curr Med Res Opin; 2009 Jun; 25(6):1385-92. PubMed ID: 19419342
[TBL] [Abstract][Full Text] [Related]
32. The direct and indirect costs of untreated insomnia in adults in the United States.
Ozminkowski RJ; Wang S; Walsh JK
Sleep; 2007 Mar; 30(3):263-73. PubMed ID: 17425222
[TBL] [Abstract][Full Text] [Related]
33. Direct and indirect costs attributable to osteoarthritis in active subjects.
Rabenda V; Manette C; Lemmens R; Mariani AM; Struvay N; Reginster JY
J Rheumatol; 2006 Jun; 33(6):1152-8. PubMed ID: 16755664
[TBL] [Abstract][Full Text] [Related]
34. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
Michaud K; Messer J; Choi HK; Wolfe F
Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
[TBL] [Abstract][Full Text] [Related]
35. The association between asthma and absenteeism among working adults in the United States: results from the 2008 medical expenditure panel survey.
Wu CH; Erickson SR
J Asthma; 2012 Sep; 49(7):757-64. PubMed ID: 22891960
[TBL] [Abstract][Full Text] [Related]
36. Incremental direct and indirect costs of untreated vasomotor symptoms.
Sarrel P; Portman D; Lefebvre P; Lafeuille MH; Grittner AM; Fortier J; Gravel J; Duh MS; Aupperle PM
Menopause; 2015 Mar; 22(3):260-6. PubMed ID: 25714236
[TBL] [Abstract][Full Text] [Related]
37. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
[TBL] [Abstract][Full Text] [Related]
38. The impact of psoriasis on health care costs and patient work loss.
Fowler JF; Duh MS; Rovba L; Buteau S; Pinheiro L; Lobo F; Sung J; Doyle JJ; Swensen A; Mallett DA; Kosicki G
J Am Acad Dermatol; 2008 Nov; 59(5):772-80. PubMed ID: 19119095
[TBL] [Abstract][Full Text] [Related]
39. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
[TBL] [Abstract][Full Text] [Related]
40. Trends in the cost of illness for asthma in the United States, 1985-1994.
Weiss KB; Sullivan SD; Lyttle CS
J Allergy Clin Immunol; 2000 Sep; 106(3):493-9. PubMed ID: 10984369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]